Tom E. Howard, MD, PhD, on a Gene Editing Approach to Treating Hemophilia A
The clinical professor in the Department of Human Genetics at University of Texas Rio Grande Valley discussed how a personalized gene editing approach may help patients avoid development of FVIII inhibitors.
Tom E. Howard, MD, PhD, on Bringing Together Knowledge of Genetic Diversity and HLA Molecules for Gene Editing Strategies
The clinical professor in the Department of Human Genetics at University of Texas Rio Grande Valley discussed research on racial differences in the Factor VIII gene that can impact treatment efficacy for hemophilia A.